In addition, more recently, Ahn et al. found that LXRα expression correlated with the degree of hepatic fat deposition, as well as with hepatic inflammation and fibrosis in NAFLD patients [16]. Here, NR1H3 is linked to metabolic dysfunction-associated steatotic liver disease.